AI assistant
Sending…
Enveric Biosciences, Inc. — Director's Dealing 2022
Jul 5, 2022
35460_dirs_2022-07-05_0675c875-5f09-4327-a00a-923326397958.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2022-06-13
Reporting Person: O'NEIL BEVIN (Director)
More from Enveric Biosciences, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 23